Market Overview

Opko Health Q4 Earnings Preview


Opko Health (NYSE: OPK) unveils its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement

Earnings and Revenue

Based on Opko Health management projections, analysts predict an earnings loss of 8 cents per share on revenue of $301.4 million.

Opko Health EPS in the same period a year ago came in at a loss of 4 cents per share and sales were $275.5 million. Revenue would be up 9.4 percent from the same quarter last year.

Here's how the company's reported EPS has compared to analyst estimates in the past:


Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate -0.05 -0.05 -0.04 -0.04
EPS Actual -0.08 -0.04 -0.06 -0.04

Stock Performance

Over the last 52-week period, shares are down -57.06 percent. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

Analysts have adjusted their estimates lower for EPS and revenues over the past 90 days. The average rating by analysts on Opko Health stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days. Most Common Rating: Neutral

Conference Call

Don't be surprised to see the stock move on comments made during its conference call. Opko Health's Q4 conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here.

Posted-In: Earnings News Previews Trading Ideas


Related Articles (OPK)

View Comments and Join the Discussion!

A Preview Of Intrexon's Q4 Earnings

Nutanix Q2 Earnings Preview